JMP Securities analyst Jason Butler downgraded Athira Pharma (NASDAQ: ATHA) from Market Outperform to Market Perform.
The analyst comments: "LIFT-AD ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE